Sarcomas

Oncology·MeSH: Sarcoma

15 drugs in development·5 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
TBI-1301	Filana Therapeutics Inc. (FLNA)

Phase 2(1)

Drug	Company
sotigalimab	Apexigen, Inc. (APGN)

Phase 1(3)

Preclinical(2)

Drug	Company
ost-tadc	OS Therapies Inc (OSTX)
ost-tadc-a	OS Therapies Inc (OSTX)

N/A(8)

Drug	Company
Ganitumab	Filana Therapeutics Inc. (FLNA)
Ganitumab	PTC THERAPEUTICS, INC. (PTCT)
Ifosfamide	PTC THERAPEUTICS, INC. (PTCT)
Pazopanib	Filana Therapeutics Inc. (FLNA)
Polyethylene Glycol	Filana Therapeutics Inc. (FLNA)
Polyethylene Glycol	PTC THERAPEUTICS, INC. (PTCT)
Temsirolimus	PTC THERAPEUTICS, INC. (PTCT)
Vincristine	PTC THERAPEUTICS, INC. (PTCT)

BioSniper tracks 15 drugs in development for Sarcomas across 5 companies.

There are 1 clinical trial targeting Sarcomas tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.